Tebra
EHR+ platform from the Kareo and PatientPop merger — charting, e-prescribing, telehealth, claims, online scheduling, and practice marketing in one independent-practice suite.
- Best for
- Independent private practices that want EHR, billing, scheduling, and growth tools together
- Price
- From $49/provider/month (public range; bundles higher)
- HQ
- United States
- Profile updated
- September 26, 2026
Worth it for your operation?
Pros
- Public pricing range on the official overview ($49–$799/provider/month by bundle)
- Cloud EHR with e-prescriptions, telehealth, labs, and AI note assist
- Billing, eligibility, and patient payments built into the same platform story
- Patient experience and practice marketing (site, reviews, acquisition) beyond a bare PM
Watch-outs
- No Meta WhatsApp inbox — HIPAA messaging and SMS are the US path
- Full-platform bundles climb quickly vs Starter-style seats
- Depth varies by specialty; confirm templates in a demo
- “Kareo” brand is legacy — evaluate Tebra as the current product
Score by criterion
The dark mark on each bar is the average of the 10 systems in this ranking. Criteria with higher weight pull the overall score more.
Native electronic health record with history, notes, and attachments — not a contact card with a PDF on the side.
Eligibility, claims, denials, and patient payments inside the product — not a separate billing company as the only path.
Recalls, campaigns, portals, or acquisition tools that keep the panel full after the first visit.
Native SMS or messaging inbox on the patient record, with team history. WhatsApp Business API also counts. One-way reminder blasts, portal-only chat, and marketplace apps do not.
Public plan in USD, trial, and what sits outside the monthly fee. Percent-of-collections quotes without a rate card lower the score for opacity.
English UI, clinical vocabulary, and time until the front desk and a provider can work without a long implementation project.
What ships natively
We only mark “yes” when the feature is part of the product — marketplace integrations or third-party apps do not count.
- Yes
Electronic health record
Native electronic health record with patient history and attachments
- Yes
Online scheduling
The patient books themselves via the vendor’s link, site, or app
- Yes
E-prescriptions
Prescriptions and certificates with digital signature without leaving the system
- Yes
Insurance billing
Insurance claims and batch billing for US payers
- Yes
Clinic billing
Accounts payable/receivable, cash, and provider payouts
- Yes
Native messaging
Native SMS or messaging inbox on the lead/contact card (history preserved). WhatsApp Business API also counts. Marketplace apps, Zapier, browser extensions, website chat buttons, and sibling-SKU modules do not
- Yes
Telehealth
Telehealth visit inside the product, not a link to another tool
- Yes
Patient acquisition & recall
Acquisition pipeline, campaigns, or patient recall sequences
Editorial analysis
Tebra in detail
Tebra is the independent-practice all-in-one on this list: clinical EHR, billing, scheduling, and the PatientPop-era growth stack under one brand. The pricing overview is unusually blunt for medical software — a published per-provider range instead of “talk to sales” only.
Who it is for
Private practices that want one login for chart, claims, and reputation — and that will actually use the marketing side. Pure hospital-employed ambulatory groups may still shortlist athenahealth or eClinicalWorks first.
What drives the score
Patient relationship and price transparency help it lead the ranking. Charting and billing stay high. Messaging scores for native SMS/portal paths when they live on the patient record.
How we read the sources
Based on tebra.com product pages and the pricing overview. Bundle math still needs a practice-specific quote inside the published range.
Frequently asked questions
Is Tebra the same as Kareo?
Kareo and PatientPop merged into Tebra. Public pages position Tebra as the current EHR+, billing, and growth platform. If you still see Kareo in old contracts or reviews, treat Tebra as the product under evaluation.
Why does Tebra often rank above heavier ambulatory suites here?
Chart and claims are strong, and the official pricing overview publishes a USD range. On this yardstick, transparency and patient-growth tools pull the overall score when clinical depth is already competitive.
Sources consulted
Everything on this profile comes from the pages below. We did not lab-test the platform.
Profile updated September 26, 2026. Found something outdated? Corrections are welcome.